April 13, 2015
(Medical Xpress) – When the United Kingdom resoundingly approved mitochondrial replacement therapy in February, it became the first country to give people this new medical option. In parallel it gave the United States serious cause to reflect on how it handles matters of reproductive innovation, argues a trio of experts in the journal Science. “We have fundamentally different regulatory cultures,” said co-author Dr. Eli Adashi, former dean of medicine and biological sciences at Brown University.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.